What are the guidelines for managing hypovolemic shock?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Hypovolemic Shock

Immediately initiate aggressive fluid resuscitation with isotonic crystalloids (normal saline or lactated Ringer's), administering a minimum of 30 mL/kg in adults and 20 mL/kg in children as rapid boluses, with the option to repeat up to 60 mL/kg in the first hour if perfusion does not normalize. 1

Initial Fluid Resuscitation

Crystalloid Administration

  • Isotonic crystalloids are the first-line fluid of choice for hypovolemic shock, with normal saline (0.9% sodium chloride) or lactated Ringer's solution as the primary options 2, 1
  • Administer rapid boluses: 250-1000 mL in adults over 5-10 minutes, or 20 mL/kg in children over 5-10 minutes 3, 1
  • Reassess hemodynamic status after each bolus before administering additional fluid 2, 1
  • In severe shock, total fluid requirements may reach 40-60 mL/kg or more in the first hour 3, 1

Colloid Considerations

  • Albumin may be used as an alternative to crystalloids for initial resuscitation, though crystalloids remain preferred 3, 2
  • Avoid hydroxyethyl starches due to increased risk of acute kidney injury and mortality 2
  • Colloids offer no mortality benefit at 28 days compared to crystalloids, though 90-day mortality may be slightly lower (exploratory finding requiring further study) 4

Hemodynamic Monitoring and Targets

Critical Assessment Parameters

  • Monitor these specific endpoints after each fluid bolus: 1
    • Mean arterial pressure (MAP) ≥65 mmHg
    • Capillary refill ≤2 seconds
    • Warm extremities with strong peripheral pulses
    • Normal mental status (reversal of altered consciousness)
    • Urine output >0.5 mL/kg/hour in adults, >1 mL/kg/hour in children
    • Decreasing serum lactate levels (aim for 20% reduction if elevated) 2, 1

Signs of Adequate vs. Excessive Resuscitation

  • Stop fluid administration if hepatomegaly or pulmonary rales develop, as these indicate fluid overload 3
  • Use dynamic measures of fluid responsiveness rather than static measures like central venous pressure alone 2

Vasopressor Support

When to Initiate Vasopressors

  • Begin vasopressor therapy if hypotension persists despite adequate fluid resuscitation (after 30-60 mL/kg crystalloid) 1
  • In children not responsive to fluid resuscitation, consider peripheral inotropic support until central venous access can be obtained, as delay in inotrope use significantly increases mortality risk 3

Vasopressor Selection and Dosing

  • Norepinephrine is the first-choice vasopressor for hypovolemic shock, targeting MAP of 65 mmHg 1, 5
  • Dilute norepinephrine 4 mg in 1000 mL of 5% dextrose solution (4 mcg/mL concentration) 5
  • Initial dose: 8-12 mcg/minute (2-3 mL/minute of diluted solution), then titrate to maintain MAP 65 mmHg 5
  • Average maintenance dose: 2-4 mcg/minute (0.5-1 mL/minute) 5
  • Administer through a large central vein when possible to avoid tissue necrosis from extravasation 5
  • Monitor blood pressure every 2 minutes until target achieved, then every 5 minutes 5

Critical Caveat on Vasopressor Use

  • Blood volume depletion must be corrected as fully as possible before vasopressor administration, except in emergency situations where intraaortic pressure must be maintained to prevent cerebral or coronary ischemia 5
  • If occult hypovolemia is suspected in patients requiring high vasopressor doses, reassess volume status with central venous pressure monitoring 5

Special Considerations

Hemorrhagic Shock

  • In hemorrhagic shock, apply permissive hypotension (systolic BP 80-90 mmHg) to limit ongoing bleeding if no contraindications exist 6
  • Administer blood products separately from crystalloids 1
  • Target hemoglobin 7-9 g/dL; in massive transfusion, use red blood cells:plasma:platelets ratio of 4:4:1 6
  • Early administration of tranexamic acid and fibrinogen is recommended to stabilize coagulation 6
  • Maintain normothermia, pH >7.2, and normocalcemia 6

Pediatric-Specific Considerations

  • Blood pressure alone is unreliable in children for assessing shock adequacy, as they maintain BP through vasoconstriction and tachycardia until cardiovascular collapse occurs 3
  • In children with severe hemolytic anemia (severe malaria or sickle cell crisis) who are not hypotensive, blood transfusion is superior to crystalloid or albumin bolusing 3

Trauma and Myoglobinuria

  • In electrical shock or trauma with significant tissue destruction, target urine output >1 mL/kg/hour to facilitate myoglobin excretion and prevent acute kidney injury 1

Common Pitfalls to Avoid

  • Never leave a patient unattended while receiving vasopressors; continuous monitoring is essential 5
  • Avoid infusing vasopressors into leg veins, particularly in elderly patients or those with occlusive vascular disease, due to increased risk of gangrene 5
  • Do not use vasopressors during cyclopropane or halothane anesthesia due to risk of ventricular arrhythmias 5
  • Gradually reduce vasopressor infusions rather than abruptly withdrawing to prevent rebound hypotension 5

References

Guideline

Management of Hypovolemia vs Hypovolemic Shock

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Fluid Resuscitation Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Hypovolaemic and haemorrhagic shock].

Deutsche medizinische Wochenschrift (1946), 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.